Results 11 to 20 of about 9,584,278 (390)

Yoga in Rheumatic Diseases [PDF]

Current Rheumatology Reports, 2013
Yoga is a popular activity which may be well suited for some individuals with certain rheumatic disorders. Regular yoga practice can increase muscle strength and endurance, proprioception and balance, with emphasis on movement through a full range of motion to increase flexibility and mobility.
Christopher Mill, Susan J. Bartlett, Susan J. Bartlett, Susan J. Bartlett, Steffany Moonaz, Clifton O. Bingham, Sasha Bernatsky   +6 more
openaire   +5 more sources

Frailty in Rheumatic Diseases [PDF]

Frontiers in Immunology, 2020
Frailty is a syndrome characterized by the decline in the physiologic reserve and function of several systems, leading to increased vulnerability and adverse health outcomes. While common in the elderly, recent studies have underlined the higher prevalence of frailty in chronic diseases, independent of age.
Francesca Motta, Francesca Motta, Antonio Sica, Antonio Sica, Carlo Selmi, Carlo Selmi   +5 more
openaire   +5 more sources

The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis

RMD Open, 2021
Objective The role of alcohol in inflammatory disease remains debated. This study explores the relationship between alcohol and disease activity in patients with inflammatory arthritis.Methods Patients attending a rheumatology clinic between 2010 and ...
Phil Gallagher, Ursula Fearon, Sinead Maguire, Matthew Turk, Yousef Alammari, Aine Gorman, Francis Young, Tajvur Saber, Lorna Freeman, Finbar O’Shea   +9 more
doaj   +1 more source

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’

Annals of the Rheumatic Diseases, 2020
Objective To investigate differences in manifestations and outcomes of coronavirus disease 2019 (COVID-19) infection between those with and without rheumatic disease.
K. D’Silva, Naomi Serling-Boyd, Rachel S Wallwork, T. Hsu, Xiaoqing Fu, E. Gravallese, Hyon K. Choi, J. Sparks, Z. Wallace   +8 more
semanticscholar   +1 more source

Photosensitivity in Rheumatic Diseases [PDF]

Journal of Investigative Dermatology Symposium Proceedings, 2004
There have been a number of recent advances in the genetic understanding of photosensitive rheumatic diseases, especially subacute cutaneous lupus erythematosus and dermatomyositis. These advances support the concept that increased numbers of ultraviolet light-induced apoptotic cells in skin lead to a supra-threshold concentration of antigenic peptides.
Victoria P. Werth, Victoria P. Werth, Wei Zhang, Muhammad M. Bashir   +3 more
openaire   +2 more sources

Glycobiology of rheumatic diseases

Nature Reviews Rheumatology, 2022
Glycosylation has a profound influence on protein activity and cell biology through a variety of mechanisms, such as protein stability, receptor interactions and signal transduction. In many rheumatic diseases, a shift in protein glycosylation occurs, and is associated with inflammatory processes and disease progression.
Kissel, T., Toes, R.E.M., Huizinga, T.W.J., Wuhrer, M.   +3 more
openaire   +3 more sources

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1

Arthritis & Rheumatology, 2020
To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic.
T. Mikuls, S. Johnson, L. Fraenkel, R. Arasaratnam, L. Baden, B. Bermas, W. Chatham, S. Cohen, K. Costenbader, E. Gravallese, A. Kalil, M. Weinblatt, K. Winthrop, A. Mudano, Amy S. Turner, K. Saag   +15 more
semanticscholar   +1 more source

Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

Annals of the Rheumatic Diseases, 2021
Background The registration trials of messenger RNA (mRNA) vaccines against SARS-CoV-2 did not address patients with inflammatory rheumatic diseases (IRD).
Y. Braun-Moscovici, M. Kaplan, Maya Braun, D. Markovits, S. Giryes, K. Toledano, Y. Tavor, K. Dolnikov, A. Balbir-Gurman   +8 more
semanticscholar   +1 more source

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

Arthritis & Rheumatology, 2020
To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic.
T. Mikuls, S. Johnson, L. Fraenkel, R. Arasaratnam, L. Baden, B. Bermas, W. Chatham, S. Cohen, K. Costenbader, E. Gravallese, A. Kalil, M. Weinblatt, K. Winthrop, A. Mudano, Amy S. Turner, K. Saag   +15 more
semanticscholar   +1 more source

Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.

New England Journal of Medicine, 2021
BACKGROUND Rheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage.
A. Beaton, E. Okello, Joselyn Rwebembera, A. Grobler, Daniel Engelman, Juliet Alepere, Lesley Canales, J. Carapetis, A. DeWyer, P. Lwabi, M. Mirabel, A. Mocumbi, M. Murali, M. Nakitto, E. Ndagire, M. C. Nunes, I. Omara, R. Sarnacki, Amy Scheel, N. Wilson, M. Zimmerman, L. Zühlke, G. Karthikeyan, C. Sable, A. Steer   +24 more
semanticscholar   +1 more source